McIntyre David

Insider CIK 1404254 · IKT Chief Financial Officer · RCEL Chief Financial Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
IKT Inhibikase Therapeutics, I	A Award deriv	2026-01-05	2026-01-07	986,319	—	$0	986,319	SEC↗
IKT Inhibikase Therapeutics, I	A Award deriv	2025-04-14	2025-04-16	1,775,539	—	$0	1,775,539	SEC↗
RCEL Avita Therapeutics, Inc.	P Buy	2020-07-17	2020-07-21	393	$22.70	$8.9K	893	SEC↗
RCEL Avita Therapeutics, Inc.	P Buy	2020-07-16	2020-07-21	300	$23.85	$7.2K	500	SEC↗